These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8351755)

  • 21. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
    García Sar D; Montes-Bayón M; Blanco González E; Sierra Zapico LM; Sanz-Medel A
    Chem Res Toxicol; 2011 Jun; 24(6):896-904. PubMed ID: 21491944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.
    Reece PA; Stafford I; Russell J; Gill PG
    J Clin Oncol; 1986 Sep; 4(9):1392-8. PubMed ID: 3746376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.
    Jacobs C; Coleman CN; Rich L; Hirst K; Weiner MW
    Cancer Res; 1984 Aug; 44(8):3632-5. PubMed ID: 6540140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
    Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods.
    Stewart DJ; Dulberg CS; Mikhael NZ; Redmond MD; Montpetit VA; Goel R
    Cancer Chemother Pharmacol; 1997; 40(4):293-308. PubMed ID: 9225947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J; Litterst CL
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
    Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
    Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity.
    Reece PA; Stafford I; Russell J; Khan M; Gill PG
    J Clin Oncol; 1987 Feb; 5(2):304-9. PubMed ID: 3806171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T; Maruta H; Ito N
    Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.
    Tamura Y; Ikeda O; Nakasone Y; Iryo Y; Yamashita Y
    Acta Radiol; 2010 May; 51(4):383-8. PubMed ID: 20192896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
    Raj GV; Iasonos A; Herr H; Donat SM
    J Clin Oncol; 2006 Jul; 24(19):3095-100. PubMed ID: 16809735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity.
    Litterst CL; Schweitzer VG
    Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.
    Hecquet B; Depadt G; Fournier C; Meynadier J
    Anticancer Res; 1986; 6(1):65-9. PubMed ID: 3954334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function and renal platinum content in uninephrectomized rats following cisplatin administration.
    Natochin YV; Reznik LV; Bakchteeva VT; Lavrova EA
    Ren Fail; 1993; 15(2):157-62. PubMed ID: 8469782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
    Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.
    Nanji AA; Mikhael NZ; Stewart DJ
    Oncology; 1986; 43(1):33-5. PubMed ID: 3941800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin.
    Cacini W; Singh Y
    Proc Soc Exp Biol Med; 1991 Jul; 197(3):285-9. PubMed ID: 2068122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells.
    Zhang L; Cooper AJ; Krasnikov BF; Xu H; Bubber P; Pinto JT; Gibson GE; Hanigan MH
    Biochemistry; 2006 Jul; 45(29):8959-71. PubMed ID: 16846239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM; van der Velde-Visser SD; van Dijk-Knijnenburg HC; van Oosterom AT; Baan RA; Berends F
    Cancer Res; 1990 Dec; 50(24):7887-94. PubMed ID: 2253228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.